Table 4.
QTL aggregateda | DSSLc | Effect estimated (days)e | Epistatic effects estimated (days)f | ||
---|---|---|---|---|---|
The spring | The fall | The spring | The fall | ||
qHd3-1/qHd6-1 b | s3-2/s6-5d | −5.8*g | −5.5*h | −5.8* | −2.1 |
qHd3-1/qHd6-2 | s3-2/s6-17 | −6.9** | −6.6** | −6.8* | −5.2* |
qHd3-1/qHd8-2 | s3-2/s8-20 | −5.3* | −7.0** | −6.4* | 1.8 |
aQTL aggregated denoted two target QTL that were used in aggregation. bQTL was nominated by qHd followed chromosomal number or -serial number. cDSSL (double substitution segment line) was developed from two SSSLs by MAS. dsi-j represented jth SSSL on chromosome i. eEffect estimated was calculated by the genetic difference between DSSL and the control. fEpistatic effect estimated equaled to the effect of DSSL subtracted the sum of two SSSL effects. gThe negative sign in the table indicated to shorten HD. h, * and ** denoted the significance at the 0.05 and 0.01 levels, respectively.